GLP-1 receptor agonists (GLP-1RAs), a class of drugs widely used to treat people with type 2 diabetes, are gaining attention for something which is beyond blood sugar control. Recent research in the ...
Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...
Real-world data show that the GLP-1 receptor agonists semaglutide and tirzepatide not only manage blood sugar and weight but also mirror their heart-protective effects from clinical trials in everyday ...
Researchers analyzing millions of safety reports identified a possible link between a popular obesity drug and an increased reporting of “eye stroke,” a condition tied to reduced blood flow to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results